BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27492273)

  • 1. Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.
    Lee J; Mark RG; Celi LA; Danziger J
    J Clin Pharmacol; 2016 Dec; 56(12):1500-1506. PubMed ID: 27492273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients.
    Chen KP; Lee J; Mark RG; Feng M; Celi LA; Malley BE; Danziger J
    J Clin Pharmacol; 2015 Jul; 55(7):774-9. PubMed ID: 25655574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
    Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
    Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
    Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study.
    Zhang Y; Ghahramani N; Razjouyan H; Ba DM; Chinchilli VM
    BMC Nephrol; 2023 May; 24(1):150. PubMed ID: 37237361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
    J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study.
    Ikuta K; Nakagawa S; Yamawaki C; Itohara K; Hira D; Imai S; Yonezawa A; Nakagawa T; Sakuragi M; Sato N; Uchino E; Yanagita M; Terada T
    BMC Nephrol; 2022 Nov; 23(1):383. PubMed ID: 36451129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitor Use Before ICU Admission Is Not Associated With Mortality of Critically Ill Patients.
    Shi L; Zhang D
    J Clin Pharmacol; 2020 Jul; 60(7):860-866. PubMed ID: 32043627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Proton Pump Inhibitor Exposure and Acute Kidney Injury After Cardiac Surgery.
    Koh HB; Joo YS; Kim HW; Jo W; Chan Kang S; Jhee JH; Han M; Lee M; Han SH; Yoo TH; Kang SW; Park JT
    Mayo Clin Proc; 2023 Feb; 98(2):266-277. PubMed ID: 36737115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of acute kidney injury in patients with HIV receiving proton pump inhibitors.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW
    J Comp Eff Res; 2019 Jul; 8(10):781-790. PubMed ID: 31167563
    [No Abstract]   [Full Text] [Related]  

  • 15. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
    Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
    Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End-Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis.
    Tsai IJ; Lai TS; Shiao CC; Huang TM; Wang CH; Tsao CH; Chen LW; Lin YH; Chen L; Wu VC; Chu TS;
    Clin Pharmacol Ther; 2020 Jun; 107(6):1434-1445. PubMed ID: 31901200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel.
    Wu CY; Chan FK; Wu MS; Kuo KN; Wang CB; Tsao CR; Lin JT
    Gastroenterology; 2010 Oct; 139(4):1165-71. PubMed ID: 20600012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton-pump inhibitor use is associated with low serum magnesium concentrations.
    Danziger J; William JH; Scott DJ; Lee J; Lehman LW; Mark RG; Howell MD; Celi LA; Mukamal KJ
    Kidney Int; 2013 Apr; 83(4):692-9. PubMed ID: 23325090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.
    Kane-Gill SL; Sileanu FE; Murugan R; Trietley GS; Handler SM; Kellum JA
    Am J Kidney Dis; 2015 Jun; 65(6):860-9. PubMed ID: 25488106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-controlled Case Series Study for Acute Kidney Injury after Starting Proton Pump Inhibitors or Potassium-Competitive Acid Blocker in Patients with Cancer Using a Large Claims Database.
    Suzuki K; Watanabe A; Kiryu Y; Inoue E; Momo K
    Biol Pharm Bull; 2024; 47(2):518-526. PubMed ID: 38403662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.